Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.
The expectations of the eventual outcomes of HIV cure research potentially differ between investigators and people living with HIV (PLHIV) [1]. Understanding expectations and experiences of PLHIV participating in ‘cure-focused’ clinical trials, particularly the risks of participation, will improve the design of future studies and the process of informed consent. This is particularly important as intervention studies do not deliver immediate clinical benefit, so participant involvement is often altruistic [2], and current studies are also not intended to cure or eradicate HIV; so they are subject to the ‘curative misconception’ [3]. It is therefore critical that investigators leading cure-related trials become aware of the information that participants may need and what participants perceive as acceptable risks [4]. In this study, we surveyed participants to understand their experiences of a cure-focused clinical trial and their general expectations of this field of research.
Full text can be obtained from publisher’s web site at:
http://journals.lww.com/aidsonline/Citation/2015/01140/Experiences_and_expectations_of_participants.16.aspx
To create and translate knowledge into better health, so no-one is left behind.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2023 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
